Name

Amvi Biotech

Legal name

Công ty Cổ phần Sản xuất Kinh doanh Dược và Trang thiết bị Y tế Việt Mỹ (American Vietnamese Biotech Incorporation)

Website

https://amvibiotech.com

Company type

Public

Founded year

2002

Operating status

Operating

Ownership category

akta.pro rank

Headquarters

HQ city

Ho Chi Minh City

HQ country

Vietnam

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Manufacturing and Sales of Medical Diagnostic Products: Production and sales of medical diagnostic biological products including rapid test kits, immunoassay reagents, and biochemical test chemicals. First domestic HIV 1&2 test kit manufacturer in Vietnam since 2011.
2. Medical Equipment Distribution: Distribution of medical equipment from major Japanese and American corporations including Tosoh, Tokyoiken, Top, Toshiba, Codonics, and IHI. Equipment includes automated analyzers, immunoassay systems, and endoscope cleaning devices.
3. Laboratory Center Investment: Investment in and operation of centralized laboratory centers following socialization model in partnership with public hospitals. Includes investment in laboratory centers at district health centers and provincial hospitals.
4. Healthcare IT Solutions: Supply of medical information technology software including HIS-RIS-PACS-EMR hospital management systems.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Core offering

Amvi Biotech manufactures medical diagnostic biological products (rapid test kits for HIV 1&2, tuberculosis, hepatitis B, immunoassay reagents, and biochemical chemicals) at a GMP-WHO certified facility in Binh Phuoc, Vietnam, using US-imported production technology. The company also distributes imported medical equipment from Japanese and American manufacturers (Tosoh, Toshiba, Codonics, IHI) to hospitals and clinics, invests in and operates centralized laboratory centers in partnership with Vietnamese public hospitals under the socialization model, and supplies HIS-RIS-PACS-EMR hospital information system software.

Product overview

Amvi Biotech operates as a medical diagnostic and healthcare equipment company offering a portfolio of medical testing equipment, software solutions, and healthcare services. The product portfolio includes automated immunoassay analyzers (AIA-900, AIA-2000, Lumipulse G600, Lumipulse G1200), tuberculosis testing systems (TRCR-80), medical dry film printers (Codonics), endoscope cleaning equipment (IHI Ozone), hospital information system software (AMVI HIS-RIS-PACS-EMR), and operates infertility treatment centers using IVF technology. The company also distributes medical equipment from Japanese manufacturers including Tosoh, Tokyoiken, Top, Toshiba, and IHI.

Differentiator

Problem solved

Functional benefit

Products and services

• Máy Xét nghiệm vi khuẩn lao TRCR-80 (TRCR-80 Tuberculosis Testing Machine)

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• JEOL (Japan Electron Optics Laboratory)coreTechnology or Integration · 10 June 2024Japanese manufacturer of electron microscopes and scientific instruments. Amvi engineers completed training (June 10-15, 2024) on testing equipment service, warranty, and maintenance according to JEOL standards.
• Furuno VietnamcoreTechnology or Integration · 1 January 2024Japanese medical equipment manufacturer. Joint scientific presentation at the 27th Vietnam Biochemistry Conference in 2024.
• FujirebiocoreTechnology or Integration · 1 January 2020Japanese in vitro diagnostics company. Joint scientific presentation at the 24th Vietnam Biochemistry Conference in 2020.
• Bệnh viện Đa khoa tỉnh Phú Thọ (Phu Tho Provincial General Hospital)coreStrategic or Co-development Partner · 1 January 2018Partnership to invest in a high-quality laboratory center at the provincial hospital following the socialization model, established in 2018.
• Công ty CP Đầu tư Bệnh viện Việt Mỹ (Vietnam America Hospital Investment JSC)coreStrategic or Co-development Partner · 1 January 2017Strategic investment partnership formed in 2017 using proceeds from strategic shareholder issuance. AMVI invested capital to establish or acquire shares in the hospital investment company.
• Công ty CP Trung tâm xét nghiệm và môi trường Cần Thơ (Can Tho Testing and Environment JSC)coreStrategic or Co-development Partner · 1 January 2017Wholly-owned subsidiary established in 2017 focusing on laboratory testing and environmental services.
• Công ty CP Sản xuất kinh doanh Dược và Trang thiết bị Y tế Phú Thọ (Phu Tho Pharmaceutical and Medical Equipment JSC)coreStrategic or Co-development Partner · 1 January 2017Wholly-owned subsidiary established in 2017 for pharmaceutical and medical equipment production and trading in Phu Tho province.
• Trung tâm y tế huyện Thanh Sơn (Thanh Son District Health Center)minorStrategic or Co-development Partner · 1 January 2017Investment in laboratory center at the district health center following socialization model, established in 2017.
• Japanese and American Medical Equipment ManufacturerscoreTechnology or Integration · 1 January 2016Partnership with major Japanese and American corporations for supply of medical equipment including Tosoh, Tokyoiken, Top, Toshiba, Codonics, and IHI brands.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Erba Mannheim: Smaller European-based IVD manufacturer focused on clinical chemistry and immunoassay reagents for emerging markets, with a strategy of partner-distributed analyzer placements similar to how Amvi pairs Fujirebio/Tosoh analyzers with locally produced reagents.
• Genrui Biotech: Chinese IVD manufacturer producing rapid-test kits and clinical chemistry analyzers for emerging Asia and Africa — comparable in manufacturing footprint and reagent breadth to Amvi Biotech.

Direct peers

• Transasia Bio-Medicals: Indian IVD and medical-equipment company with a hybrid manufacturing-plus-distribution model and emerging Asia footprint, comparable to Amvi's mix of domestically produced diagnostics plus Japan/USA-branded analyzers.
• Mindray: Chinese manufacturer of in-vitro diagnostics analyzers, reagents, and medical devices; comparable to Amvi on the equipment and consumables portfolio targeting public hospitals across emerging Asia.
• Trivitron Healthcare: Indian medical-technology company combining in-house diagnostic reagent manufacturing with multi-brand equipment distribution and hospital laboratory solutions across emerging Asia — directly analogous to Amvi's three-pillar model of kit manufacturing, Japan/US equipment distribution, and central lab investments.
• SD Biosensor: Korean in-vitro diagnostics manufacturer with a flagship rapid-test kit portfolio (HIV, tropical disease, infectious disease) similar to Amvi's home-grown test-kit business, and a comparable emerging-market commercialization model targeting Asia and Africa.

Broad incumbents

• Sysmex: Large Japanese IVD and hematology company and current Amvi principal/partner via its AIA-900 and AIA-2000 immunoassay analyzers; a broad incumbent whose product lines Amvi distributes across Vietnam.
• Hologic: US-headquartered diagnostics and women's-health company with IVD instruments and assays distributed into hospital labs; overlaps with Amvi's automated immunoassay and immunoassay-analyzer business.
• Abbott Diagnostics: Global IVD division of Abbott, one of the largest diagnostic-reagent and analyzer businesses in the world; competes with Amvi's Japanese/USA distributed platforms in Vietnamese central labs.
• bioMérieux: Global IVD major covering microbiology, immunoassays, and molecular diagnostics; broader in scope than Amvi but competes in the same reagent and analyzer categories Amvi distributes to Vietnamese hospitals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amvi Biotech